Search

everythinglearnresearchcommunity

for

Search:↓

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Certain drugs that block specific enzymes can help treat prostate diseases.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.